Ebola Virus Infectivity: Extremely Low Infectious Dose

Ebolaviruses are among the most infectious known pathogens. Experimental and epidemiological evidence indicates:

  • Infectious dose (ID50): Estimated at 1–10 viral particles via parenteral or mucosal exposure in nonhuman primates. Human data consistent with extremely low dose.
  • Comparison: Influenza ID50 ~100–1,000 particles; SARS-CoV-2 estimated ~100–1,000; Norovirus ~18 particles.

Why So Infectious?

  • Broad cell tropism: Infects macrophages, dendritic cells, endothelial cells, hepatocytes, fibroblasts via multiple receptors (NPC1, TIM-1, integrins).
  • Rapid replication: High viral loads (107–109 RNA copies/mL blood) within days.
  • Immune evasion: VP35 and VP24 proteins block interferon signaling, delaying innate/adaptive responses.
  • Cell-to-cell spread: Syncytia formation and virological synapses enhance dissemination.
  • Environmental stability: Persists days in body fluids on surfaces at room temperature; longer in cold/wet conditions.

Transmission Implications

  • Minute fluid exposures (needlestick, splash to mucosa) can transmit.
  • High viral loads in late-stage patients → extreme infectiousness of bodies/fluids.
  • Explains nosocomial amplification without rigorous IPC.
  • Does not imply airborne transmission—still requires direct contact with infectious material.

This extreme infectivity underscores the need for maximum barrier precautions and zero-tolerance for protocol breaches in clinical and laboratory settings.

Viral Infections - Related Articles